Presentation is loading. Please wait.

Presentation is loading. Please wait.

ASPIRE CLASS 3: Choosing Your Study Design and Population

Similar presentations


Presentation on theme: "ASPIRE CLASS 3: Choosing Your Study Design and Population"— Presentation transcript:

1 ASPIRE CLASS 3: Choosing Your Study Design and Population
Kari L. Olson, BSc(Pharm), Pharm D, FCCP, BCPS (AQ Cardiology)

2 Learning Objectives Class 2: Study Designs and Population ASPIRE
Assess the advantages and disadvantages of various study designs, Compose study population selection criteria for your study Differentiate between internal and external validity and generalizability bias and confounding

3 Elements of a Research Protocol
Background Population Study Design Objectives Procedures Analytical Plan

4 Hierarchy of Evidence

5 Study Designs Bias $ Primary Study Designs Experimental Studies:
Randomized controlled trial Non-randomized controlled trial Observational Studies: Cohort Case-control Before/after with no control Cross-sectional Case series/case reports $ Bias One area to differentiate b/w experimental vs. observational studies. Efficacy studies, ie. demonstrating whether something is “efficacious” is conducted in controlled experimental research trial. A study that shows a treatment approach to be “efficacious” means that the study produced good outcomes, which were identified in advance, in a controlled experimental trial, often in highly constrained conditions. Phase III drug studies are good examples for efficacy trials. Effective treatment provides positive results in a usual or routine care condition that may or may not be controlled for research purposes but may be controlled in the sense of specific activities are undertaken to increase the likelihood of positive results. Effectiveness studies use real-world clinicians and clients, and clients who have multiple diagnoses or needs. These can also be randomized, however the conditions are less constrained than that of efficacy trials. CER

6 Study Designs A few ways to do it... Exposure Disease/Outcome
Population at time X look at exposure and outcome

7 What is a cohort? Cohort: Two purposes:
Group of people who have something in common Single group or multiple groups Two purposes: Descriptive measures of frequency, incidence rates or describe natural history of disease Analytic associations between rates of outcomes, risk factors, or predictors of outcome

8 Cohort Studies Longitudinal, follow-up, or observational study
Identify subjects, then observe and record characteristics over time to measure outcomes Retrospective, prospective or before/after (pre/post) Time-order relationships clear in cohort studies

9 Observational Study: Prospective Cohort
Experimental Exposure No Exposure With outcome Without Subjects selected for the study RANDOMIZATION Without outcome With outcome Today Time

10 Example of Prospective Cohort Study
Study Objective: to determine if endogenous 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels are associated with increases in all-cause and cardiovascular mortality Jul ’97 to Jan ‘00 Today 3258 patients scheduled for coronary angiography enrolled; Vit D levels drawn Outcomes: All-Cause Mortality Cardiovascular Mortality Study End Lower Vit D Quartiles What is good about prospective cohort study is that you can ensure that all patients have required labs drawn, in this instance, Vit D levels before follow-up Cohort studies evaluate ‘associations’ but can do little to assess ‘causality’, Causality can really only be assessed with experimental studies. Also, cohort studies are useful if you are determining risks where randomization may not be ethical. Follow-up 7.7 yrs Higher Vit D Quartiles All-cause: HR 2.1, CV: HR 2.2, Arch Intern Med 2008;168:

11 Cohort Study to Experimental Study
Study Objective: to determine if supplementing with Vitamin D reduces all-cause and cardiovascular mortality among patients undergoing coronary angiography Follow-up 7.7 yrs Jul ’97 to Jan ‘00 Today 3258 patients scheduled for coronary angiography enrolled; Vit D levels drawn Lower Vit D Quartiles Higher Vit D Outcomes: All-Cause Mortality Cardiovascular Mortality Study End RANDOMIZE Vit D or placebo Arch Intern Med 2008;168:

12 Observational Study: Retrospective Cohort
Subjects selected for the study Exposure No Exposure With outcome Without Can look similar to a proscpective cohort, except that everything occurs in the past rather than prospective x Time Today

13 Example of Retrospective Cohort Study
Time x Today Lower Vit D Quartiles 3258 patients scheduled for coronary angiography enrolled; Vit D levels drawn Follow-up 7.7 yrs Outcomes: All-Cause Mortality Cardiovascular Mortality Higher Vit D Quartiles You could mimic the prospective cohort design we just discussed but change your time to today and look backwards. In this case, because the data have already been collected in the past but we are following pts in time (albeit retrospectively), this would be a longitudinal, retrospective, cohort study. Some problems with this is ensuring all pts have the required data, for instance Vit D levels. You would have to limit your sample to just those pts who had a Vit D level drawn which could introduce some bias in patient selection and thus limit interpretation of the outcome. Jul ’97 to Jan ‘00 Arch Intern Med 2008;168:

14 Cohort Studies Advantages Disadvantages Can study multiple outcomes
Can study uncommon outcomes or outcomes associated with risk Selection bias less likely Gives you incidence data Can be expensive Can take time (prospective)

15 x Observational Design: Case-control Studies Today Exposure Cases Yes
Subjects with condition ('cases') matched with patients without condition (‘controls’) Exposure Yes No Cases Look back in time Controls Today x

16 Example of Case-Control Study
N Engl J Med 2000;343: Study Objective: To determine the association between phenylpropanolamine and hemorrhagic strokes Exposed to phenylpropanolamine? Cases: pts with hemorrhagic stroke Yes No Look back in time Yes No Controls: patients with no hemorrhagic stroke x Today

17 Observational Designs: Case-control Studies
Advantages: rare diseases, short time periods, inexpensive, can study multiple potential causes Disadvantages: bias, validation on exposure difficult, does not provide incidence of disease, choice of control group difficult, difficult interpreting results

18 Observational Study: Pre/Post Cohort
No exposure to intervention “Pre” Period Exposure to intervention “Post” Period Without outcome With “Baseline” Without outcome With “Follow-up” Subjects identified for study Time Time Can be done prospectively or retrospectively, however given typically no comparator group, you probably want to

19 No exposure to intervention
Observational Study: Pre/Post Cohort Study Objective: to assess the effect of an electronic prescribing (EP) system on the incidence and type of prescribing errors and the number of error-free visits No exposure to intervention Exposure to intervention Without outcome With “Baseline” Without outcome With “Follow-up” 520 outpatients in nephrology clinic in tertiary pediatric hospital Time Time

20 Cohort Studies: Pre/Post Studies
Advantages Disadvantages Quick and relatively easy to implement Hypothesis generating by which to design experimental studies Typically, no control group by which to compare outcomes Subject to bias Regression to the mean

21 Observational Designs: Cross-sectional
Observation of a defined population at a single point in time or time interval Advantages: estimates of prevalence, quick, inexpensive Disadvantages: not controlled, can not assess causality, impractical for rare diseases

22 Observational Designs: Case-series/case reports
Association b/w observed effect and exposure based on detailed clinical evaluation Advantages: hypothesis generating identify unusual situations Disadvantages: short term, selection bias, not controlled

23 Enhancing Causal Inferences in Observational Studies
Spurious Associations Chance (random error) limit by calculating sample size Bias (systematic error) Selection bias, measurement bias, surveillance, information (recall, interviewer, non-response), misclassification Select appropriate population, predictor, and outcomes Matching Real Associations Effect-cause Confounding Adjust outcome with variables that are different between groups Observational studies allow to assess associations, not causality. Causality can only really be tested in randomized controlled designs. Again, the purpose of randomization is to control for known and unknown (unmeasurable) differences in the population. In observational studies, in which randomization has not occurred, there are a number of things to consider/address to help enhance causal inferences. Effect-Cause: comparator groups, use time Associated with the predictor variable and is a cause for the outcome

24 To determine the impact of smoking on lung cancer rates
Objective: To determine the impact of smoking on lung cancer rates Choose the most appropriate study design? Randomized Controlled Study Case Controlled Study Cross-Sectional Study Prospective Cohort Study

25 To describe osteonecrosis of the jaw associated with alendronate
Objective: Choose the most appropriate study design? Randomized Controlled Study Case Series Cross-Sectional Study Prospective Cohort Study To describe osteonecrosis of the jaw associated with alendronate

26 Writing Study Design in Protocol
Summarize in 1-sentence Think about design issues, limitations of the design, and try to address them as you move through methods Also state in this section the IRB requirements for your proposal

27 Elements of a Research Protocol
Background Population Study Design Objectives Procedures Analytical Plan

28 Study Population Population: Sample: Target population: Study sample:
complete set of people with a specified set of characteristics Sample: subset of the population Target population: the population to which the results will be generalized Study sample: subset of the target population

29 Selecting the Study Population
1st step in narrowing down target population Helps address to which population results will be generalizable Should flow logically and directly from research question/hypothesis Provide standards as to whether a patients should enter a study No real guidelines on how to come up with these

30 Selection Criteria Determine target population Inclusion criteria
Clinical, demographic, socioeconomic characteristics Inclusion criteria What should subjects possess to be included KPCO membership Exclusion criteria What would preclude participation? High loss to follow-up, provide poor data, side effects/safety issue Determine method to be used to assess eligibility Who, what, how? Methods of recruitment and by whom

31 Vulnerable Populations
Children Pregnant Women Elderly Minorities Students, employees Non-english speakers Terminally ill Prisoners

32 Are my results valid and generalizable?
Validity (i.e. accuracy) Is the study able to scientifically answer the questions it is intended to? Internal validity the degree to which conclusions about causal relationships can be made based External validity The degree to which results of a study can be true in other cases (i.e. different populations, settings) Generalizability Internal validity: based on the measures used, the research setting, and the research design, etc External validity : If the same research study was conducted in those other cases, would it get the same results?. A major factor in this is whether the study sample (e.g. the research participants) are representative of the general population along relevant dimensions.

33 Will your research produce valid findings?
Threats to Validity Chance Bias Ways that the targeted and sample populations differ Systematic or measurement errors Not random errors Confounding

34 Criteria to think about
How do the criteria affect internal and external validity of the study? Are the criteria necessary for the safety of the participants? Are the criteria ethical? How will the criteria be determined? Validity Generalizability

35 Class 3 Assignment Prepare a 5-10 min presentation for your small group session including draft versions of the following: Study design and setting Study population inclusion and exclusion criteria Are you including/excluding any vulnerable populations? Be prepared to discuss generalizability and validity of your selection criteria Please come prepared with the above items September 3, 2:30-5:00 Kaiser Permanente Central Support Services


Download ppt "ASPIRE CLASS 3: Choosing Your Study Design and Population"

Similar presentations


Ads by Google